Starpharma to Advance With Phase III Studies for VivaGel

Starpharma has kicked off the year with a tick from the U.S. Food and Drug Administration for its study design for Phase III trials of VivaGel under the FDA’s Special Protocol Assessment scheme.
Australian Life Scientist